Amedisys Inc (AMED)
Current ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 496,935 | 467,227 | 426,544 | 405,557 | 388,961 | 388,780 | 394,869 | 392,485 | 356,684 | 432,882 | 390,965 | 380,450 | 361,984 | 411,250 | 449,540 | 468,128 | 350,554 | 299,519 | 275,785 | 271,731 |
| Total current liabilities | US$ in thousands | 473,721 | 468,119 | 462,401 | 353,050 | 355,529 | 367,200 | 427,372 | 380,154 | 374,282 | 454,349 | 449,223 | 456,082 | 456,337 | 437,496 | 442,048 | 316,106 | 326,943 | 314,653 | 313,007 | 297,377 |
| Current ratio | 1.05 | 1.00 | 0.92 | 1.15 | 1.09 | 1.06 | 0.92 | 1.03 | 0.95 | 0.95 | 0.87 | 0.83 | 0.79 | 0.94 | 1.02 | 1.48 | 1.07 | 0.95 | 0.88 | 0.91 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $496,935K ÷ $473,721K
= 1.05
The current ratio of Amedisys Inc. has shown some fluctuations over the past eight quarters. The ratio indicates the company's ability to cover its short-term liabilities with its short-term assets. A current ratio below 1.0 may signal liquidity issues, while a ratio above 1.0 typically suggests the company is able to meet its short-term obligations.
In Q4 2023, the current ratio was 1.05, indicating that Amedisys had $1.05 in current assets for every $1.00 in current liabilities. This suggests a healthy liquidity position.
In Q3 2023, the current ratio was 1.00, indicating a balance between current assets and current liabilities.
In Q2 2023, the current ratio decreased to 0.92, which may raise concerns about the company's ability to cover its short-term obligations. However, it improved in Q1 2023 to 1.15, indicating a better liquidity position.
Comparing the latest ratio to the same quarter in the previous year, we see a slight increase from Q4 2022 (1.09) to Q4 2023 (1.05), which is a positive sign. However, there has been some variability in the interim quarters.
Overall, while the current ratio has fluctuated, Amedisys has generally maintained a current ratio above 1.0 in recent quarters, indicating that the company generally has sufficient current assets to cover its current liabilities. Investors and stakeholders should continue to monitor the trend to ensure the company's liquidity remains stable.
Peer comparison
Dec 31, 2023